Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4K Buy
1,500
+800
+114% +$14.3K ﹤0.01% 3044
2026
Q1
$13.3K Sell
700
-29,800
-98% -$576K ﹤0.01% 3079
2025
Q4
$499K Sell
30,500
-24,500
-45% -$431K ﹤0.01% 2236
2025
Q3
$1.03M Buy
+55,000
New +$986K ﹤0.01% 1928

Other funds holding XP

Marshall Wace's XP Position: Q2 2026 in Review

Marshall Wace increased its XP (XP) stake by 101% in Q2 2026, buying an estimated $58.6M and bringing the position to 6,528,760 shares worth $106M. The position accounts for 0.08% of the portfolio, ranked #186.

Marshall Wace first reported a position in XP in Q4 2019 and has held it in 18 quarters since. 321 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Marshall Wace held 6,528,760 shares of XP worth $106M as of Q2 2026.
  • Marshall Wace bought 3,288,393 XP shares in Q2 2026, an estimated $58.6M.
  • XP made up 0.08% of Marshall Wace's portfolio in Q2 2026, its #186 holding.
  • Marshall Wace first reported a position in XP in Q4 2019 and has held it in 18 quarters since.
  • 321 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.